CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 35 enrolled
Drug / intervention
Facial Cleanser and Moisturizer SPF 30drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01909713
NCT01909713Phase 4Completed
CompareCT.gov

Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.

Galderma R&D·interventional·Posted Jul 26, 2013·Updated Aug 23, 2022

In Brief

A Phase 4 clinical trial evaluating Facial Cleanser and Moisturizer SPF 30 for Acne Prone Skin. Completed, enrolled 35 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the tolerability of Cetaphil® DermaControl™ Foam Wash and Moisturizer SPF 30 in pediatric subjects (7-11) with acne prone skin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Prone Skin
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 26, 2013
Enrollment StartMay 1, 2013
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.9 years ago

Interventions

Facial Cleanser and Moisturizer SPF 30drug

Cetaphil® DermaControl™ Foam Wash and Moisturizer SPF 30